Factors affecting levodopa effects in Parkinson's disease

被引:0
|
作者
Ogawa, N [1 ]
机构
[1] Okayama Univ, Sch Med, Inst Mol & Cellular Med, Dept Neurosci, Okayama 7008558, Japan
关键词
dopamine agonist; monoamine oxidase-B (MAO-B) inhibitor; catechol-O-methyltransferase (COMT) inhibitor; blood-brain barrier; age at onset; large neutral amino acids; gastric acidity;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Levodopa is the gold standard for the treatment of Parkinson's disease (PD) because of its outstanding clinical efficacy. However, the majority of patients experience various adverse reactions, including the wearing-off phenomenon, the on-off phenomenon, dyskinesia and psychiatric symptoms. The response to levodopa depends not only on the intrinsic responsiveness of the patients, but also on various other important factors including the type of levodopa preparation, its absorption/metabolism, the blood-brain barrier, age at onset of disease and concomitant use of anti-parkinsonian drugs. This review summarizes factors which influence the effects of levodopa in PD, To minimize levodopa-induced adverse reactions and to relieve long-term parkinsonian symptoms,levodopa therapy should be conducted by taking these factors into consideration.
引用
收藏
页码:95 / 101
页数:7
相关论文
共 50 条
  • [1] Cardiovascular effects of levodopa in Parkinson's disease
    Noack, Cornelia
    Schroeder, Christoph
    Heusser, Karsten
    Lipp, Axel
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (08) : 815 - 818
  • [2] The effects of levodopa on word intelligibility in Parkinson's disease
    De Letter, M
    Vantens, P
    Van Borsel, J
    JOURNAL OF COMMUNICATION DISORDERS, 2005, 38 (03) : 187 - 196
  • [3] Effects of levodopa on cognitive functions in Parkinson's disease
    Ismailova, S.
    Prokopenko, S.
    MOVEMENT DISORDERS, 2021, 36 : S293 - S293
  • [4] Effects of levodopa on pulmonary function in Parkinson's disease
    Herer, B
    Arnulf, I
    Housset, B
    CHEST, 2001, 119 (02) : 387 - 393
  • [5] Effects of Levodopa on Postural Strategies in Parkinson's disease
    Baston, Chiara
    Mancini, Martina
    Rocchi, Laura
    Horak, Fay
    GAIT & POSTURE, 2016, 46 : 26 - 29
  • [6] Effects of levodopa on saccade performance in Parkinson's disease
    Yugeta, A.
    Terao, Y.
    Fukuda, H.
    Ugawa, Y.
    MOVEMENT DISORDERS, 2008, 23 (01) : S296 - S297
  • [7] Factors Affecting Pain in Parkinson's Disease
    Rana, Abdul Qayyum
    Khan, Adeel
    Uppal, Russell
    Galange, Patrick
    Yosuf, Muhammad Saad
    Siddiqui, Ishraq
    Jesudasan, Ajantha
    Rana, Afshan Nazli
    Abounaja, Mohammad
    Hafez, Kevin
    Rana, Mohammed Abdullah
    JOURNAL OF PARKINSONS DISEASE, 2012, 2 (04) : 273 - 279
  • [8] Levodopa and Parkinson's disease
    Valkovic, P.
    Blazicek, P.
    Benetin, J.
    Kukumberg, P.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2006, 69 (03) : 183 - 188
  • [9] Axial kinesthesia is impaired in Parkinson's disease: Effects of levodopa
    Wright, W. G.
    Gurfinkel, V. S.
    King, L. A.
    Nutt, J. G.
    Cordo, P. J.
    Horak, F. B.
    EXPERIMENTAL NEUROLOGY, 2010, 225 (01) : 202 - 209
  • [10] Protease inhibitors enhance levodopa effects in Parkinson's disease
    Caparros-Lefebvre, D
    Lannuzel, A
    Tiberghien, F
    Strobel, M
    MOVEMENT DISORDERS, 1999, 14 (03) : 535 - 535